UBS Group
EXAS

UBS Group’s Exact Sciences EXAS Stock Holding History

UBS Group’s Portfolio EXAS Stock Details EXAS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-39,400
Closed -$2.09M – 10472
2025
Q2 		$2.09M Buy
+39,400
New +$2M ﹤0.01% 4770
2024
Q2 		– Sell
-26,100
Closed -$1.8M – 9672
2024
Q1 		$1.8M Buy
+26,100
New +$1.65M ﹤0.01% 4050
2022
Q3 		– Sell
-49,600
Closed -$1.95M – 10497
2022
Q2 		$1.95M Sell
49,600
-22,400
-31% -$1.2M ﹤0.01% 3171
2022
Q1 		$5.03M Buy
+72,000
New +$5.26M ﹤0.01% 2529
2021
Q1 		– Sell
-4,000
Closed -$530K – 9112
2020
Q4 		$530K Hold
4,000
– – ﹤0.01% 4559
2020
Q3 		$408K Hold
4,000
– – ﹤0.01% 4342
2020
Q2 		$348K Hold
4,000
– – ﹤0.01% 4410
2020
Q1 		$232K Buy
+4,000
New +$325K ﹤0.01% 4603
2016
Q4 		– Sell
-50,000
Closed -$929K – 7834
2016
Q3 		$929K Buy
+50,000
New +$881K ﹤0.01% 3487
2016
Q1 		– Sell
-100
Closed -$1K – 7781
2015
Q4 		$1K Hold
100
– – ﹤0.01% 8141
2015
Q3 		$2K Hold
100
– – ﹤0.01% 8076
2015
Q2 		$3K Hold
100
– – ﹤0.01% 8061
2015
Q1 		$2K Sell
100
-1,100
-92% -$27.9K ﹤0.01% 8441
2014
Q4 		$33K Buy
+1,200
New +$29.2K ﹤0.01% 6996

Other funds holding EXAS

VanEck Associates
VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
PRS
Pinkerton Retirement Specialists Coeur D Alene, Idaho $1.1B AUM 30.57% 1-Year Est. Return
PWMAG
Pinnacle Wealth Management Advisory Group Red Bank, New Jersey $1.46B AUM 22.77% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return
BC
Broadwater Capital Boston, Massachusetts $138M AUM 28.86% 1-Year Est. Return

UBS Group's EXAS Position: Q1 2026 in Review

UBS Group sold out of Exact Sciences (EXAS) in Q1 2026, closing a stake of 2,989,407 shares — an estimated $304M sold.

UBS Group first reported a position in EXAS in Q4 2014 and held it in 45 quarters. The position peaked at $304M in Q4 2025. 7 funds tracked by Wall St. Rank hold EXAS as of Q1 2026.

  • UBS Group reported no remaining Exact Sciences position as of Q1 2026 after selling out during the quarter.
  • UBS Group sold 2,989,407 Exact Sciences shares in Q1 2026, an estimated $304M.
  • UBS Group first reported a position in Exact Sciences in Q4 2014 and held it in 45 quarters.
  • UBS Group's Exact Sciences position peaked at $304M in Q4 2025.
  • 7 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2026.

Based on UBS Group's 13F filing for Q1 2026, filed 5 May 2026.